Send us Feedback

Psychemedics (PMD)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Psychemedics Awarded Patent Fundamental To Hair Analysis Drug Testing
Benzinga  Jan 24  Comment 
Psychemedics Corporation (NASDAQ: PMD) announced today that the United States Patent Office issued a seventh patent, US No. 8,084,215, to the company. This patent focuses on liquefying hair and releasing drugs trapped in the hair without...
Ministries set Dec 10 deadline to submit action plan on curbing corruption
The Hindu Business Line  Aug 30  Comment 
The Performance Management Division (PMD) of the Cabinet Secretariat will sit with secretaries of 74 Central Ministries and departments for finding ways to identify potential areas...
PetroMagdalena To Farm Out 30% Of The Santa Cruz Block
OilVoice  Aug 26  Comment 
PetroMagdalena Energy Corp. TSXV PMD has signed a letter of intent to farm out 30 of the Santa Cruz Block in which the Company holds a 100 working interest for a carry of 60 of the first explo
Psychemedics Corporation Reports Q4 EPs of $0.08
Benzinga  Mar 2  Comment 
Psychemedics Corporation (Nasdaq: PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2010. The Company also announced a quarterly dividend of $0.12 per share payable to shareholders of record as...
Psychemedics (PMD) Tops Q3 Earnings Views
StreetInsider.com  Nov 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Psychemedics+%28PMD%29+Tops+Q3+Earnings+Views/6077793.html for the full story.
Psychemedics Corporation Announces Third Quarter EPS of $.16
Benzinga  Nov 4  Comment 
Psychemedics Corporation (Nasdaq: PMD) today announced third quarter financial results for the period ended September 30, 2010. The Company's revenue for the quarter ended September 30, 2010 was $5.1 million versus $4.7 million for the quarter...
StemCells, Inc. Reports Progress in Myelination Disorder Trial
Globe Newswire  Oct 7  Comment 
PALO ALTO, Calif., Oct. 7, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today provided an update on its ongoing Phase I clinical trial in Pelizaeus-Merzbacher Disease (PMD), a fatal myelination disorder that afflicts male children.  Two of
Big Board Stocks Highs and Lows
Penny Stock DD  Sep 10  Comment 
•  Psychemedics (PMD) hit a new 52-week high of $9.70.  The provider of hair testing services to detect illegal drugs is jumping more than 4% today.  Their market cap is just over $49 million. •  Green Mountain Coffee Roasters (GMCR)...
Psychemedics Corp. (PMD) Posts Stronger Q1 Results
StreetInsider.com  May 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Psychemedics+Corp.+%28PMD%29+Posts+Stronger+Q1+Results/5622717.html for the full story.
Psychemedics (PMD) Names James Dyke as V.P. of Sales
StreetInsider.com  Apr 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Psychemedics+%28PMD%29+Names+James+Dyke+as+V.P.+of+Sales/5511286.html for the full story.
Sales Expert and Author Offers "Spring Training" for Sales Professionals -- a Two-Day Sales Training Seminar Packed With Tools for Winning on the Sales Field
Marketwire  Apr 7  Comment 




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Psychemedics_(PMD)"
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki